Posted: 2017-01-03 in Press Releases
CE mark secured for next generation PKG™ system
Global Kinetics Corporation has secured CE marking on its second generation Parkinson’s KinetiGraph™ (PKG™) System, indicating that the product complies with EU health and safety requirements and legislation.
The system has also recently received clearance from the US Food and Drug Administration (FDA) and has been introduced in Australia, where it received avid support from patients.
The CE marking of the new technology underpins GKC’s aggressive expansion into new product and service offerings to meet the needs of the Parkinson’s community worldwide. It also enables us to build upon the already substantial partnerships with global pharmaceutical and device leaders in the area of Parkinson’s.
The new technology will be introduced to patients and clinicians in twelve leading European movement disorder clinics in the next two months, with a full rollout to follow thereafter.
The second generation PKG™ is an important development that will deliver a new era of
impact for patients around the world.
Timothy I. Still
President and CEO
Global Kinetics Corporation